:

Jiaxin Xie1,2, Xuesi Dong1,2, Zilin Luo1,2

  • 1Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

PLoS medicine
|November 26, 2025
PubMed
概括

改善结肠直肠癌 (CRC) 查参与度可以提高健康效益和成本效益. 在中国,问卷加便免疫化学测试 (FIT) 是成本高效的,而新的生物标志物测试需要更低的成本和更高的吸收率.